Part of the Problem: Sen. Max Baucus

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


max-baucus.jpg Montana Senator Max Baucus, head of the Senate Finance Committee, has rightfully been called “one of corporate America’s favorite Democrats.” It’s no surprise, then, that he’s all lobbied up.

Since 1996, one-fifth of U.S. Sen. Max Baucus’ highest-paid staff members have left their jobs to become lobbyists, usually for industries regulated by the powerful committee that Baucus heads, a Missoulian State Bureau analysis shows.

Take Jeff Forbes, for example. In 2003, Forbes was Baucus’ lead staffer on the Senate Finance Committee working extensively on the Medicare prescription drug bill. Baucus, then the top-ranking Democrat on the panel, was one of the bill’s central architects.

In late November, just five days before the Senate took the final, key vote on the bill, Forbes quit. Six weeks later, he was registered to lobby for two drug companies and the Pharmaceutical Research and Manufacturers of America (PhRMA), the lobby representing the nation’s biggest prescription drug companies.

Those same companies got a multimillion-dollar windfall in the Medicare drug program, critics of the program contend, because the law forbids the government from negotiating with drug manufacturers for cheaper prices.

The Nation reported in 2007 that Baucus once asked 50 lobbyists to raise $100,000 each for his upcoming re-election campaign. If Barack Obama becomes the standard-bearer of his party, he’s going to have to decide if, in his quest to cleanse the system in Washington, he wants to demand change from powerful members of his own party.

LESS DREADING, MORE DOING

This is the rubber-meets-road moment: the early days in our first fundraising drive since we took a big swing and merged with CIR to bring fearless investigative reporting to the internet, radio, video, and everywhere else that people need an antidote to lies and propaganda.

Donations have started slow, and we hope that explaining, level-headedly, why your support really is everything for our reporting will make a difference. Learn more in “Less Dreading, More Doing,” or in this 2:28 video about our merger (that literally just won an award), and please pitch in if you can right now.

payment methods

LESS DREADING, MORE DOING

This is the rubber-meets-road moment: the early days in our first fundraising drive since we took a big swing and merged with CIR to bring fearless investigative reporting to the internet, radio, video, and everywhere else that people need an antidote to lies and propaganda.

Donations have started slow, and we hope that explaining, level-headedly, why your support really is everything for our reporting will make a difference. Learn more in “Less Dreading, More Doing,” or in this 2:28 video about our merger (that literally just won an award), and please pitch in if you can right now.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate